CapEval Pharma has no proprietary projects or programs meaning that all of our clients are equally important to us. We welcome both short and long-term appointments and we offer our clients a flexible and cost effective approach based on their needs and scope of work. Projects can be undertaken at the offices of the client or from our offices in France, Geneva area or Germany. After initiating a CDA, to allow sharing of confidential information, we will provide a tailored contract stating the scope of work, proposed service arrangement and expected timeframe for the project. We offer the following flexible service arrangements to meet the needs of our clients and business partners:
  • Competitive hourly rate – for less well defined projects and shorter term work
  • Full-time-equivalent (FTE) – a flat monthly rate which can be cost effective for larger scope projects
  • FFS (Fee for service) – Pre-agreed fixed fee for a defined body of work
  • Milestone-type arrangement – Lower fee from the start with additional payments depending on predefined goals.

Classical Non-Clinical Drug Safety

  • Genotoxicity Studies
  • Safety Pharmacology Studies
  • Development & Reproduction Toxicity
  • Acute to chronic toxicity
  • Carcinogenicity

”A la carte” NCD Strategy & Support Services

Discovery to Submission Phases

  • Exploratory /mechanistic experiments & regulatory studies implementation
  • Data analysis (interpretation & reporting), report writing/checking/supervising
  • Advise & support projects teams
  • R&D programs coherent with regulatory constraints
  • Flexible project management adapted to findings (mechanistic studies target organ-oriented)
  • Monitoring studies
  • Lead selection
  • Target organ identification

NCD Strategy and support

  • CRO (North America, Europe, Asia) assessment, selection, justified choice, audits & monitoring
  • Consulting for development of new molecules
  • Strategic assessment
    • Efficacy
    • ADME
    • PK
    • Safety & adverse effects of various compounds
  • Due Diligence (in/out licensing & partnership opportunities)
  • Scientific assessment/contribution to negotiation
  • Support, advices & training